Literature DB >> 31043060

Rapid growth predisposes broilers to necrotic enteritis.

E Dierick1, O P Hirvonen2, F Haesebrouck1, R Ducatelle1, F Van Immerseel1, E Goossens1.   

Abstract

Over the past 50 years, intentional genetic selection within the broiler industry has led to major improvements in both body weight gain (BWG) and feed conversion efficiency. Next to its economic advantages, enhancing BWG can increase the risk of metabolic and skeletal disorders. The aim of this study was to examine whether higher BWG is a predisposing factor for broiler necrotic enteritis. In this study, 300 broilers were challenged with Clostridium perfringens using a well-established, previously described challenge model. It was found that birds with higher body weight (BW) and BWG before challenge were predisposed to develop more severe necrotic enteritis lesions. After challenge, the average BWG of the birds developing mild to severe lesions dropped significantly, negatively affecting bird welfare and performance. These results show a significant interplay between BWG and the development of necrotic enteritis lesions. This raises the question whether there is a limit to broiler performance with respect to maintaining intestinal health, and whether decreasing BWG (at certain stages of the growth cycle) can be part of a plan to prevent intestinal pathology. RESEARCH HIGHLIGHTS Higher body weight is a predisposing factor to necrotic enteritis in broilers.

Entities:  

Keywords:  Necrotic enteritis; body weight gain; broiler; growth rate; predisposing factor

Year:  2019        PMID: 31043060     DOI: 10.1080/03079457.2019.1614147

Source DB:  PubMed          Journal:  Avian Pathol        ISSN: 0307-9457            Impact factor:   3.378


  7 in total

1.  Dietary resistant starch ameliorating lipopolysaccharide-induced inflammation in meat ducks associated with the alteration in gut microbiome and glucagon-like peptide 1 signaling.

Authors:  Simeng Qin; Weiqiang Bai; Todd J Applegate; Keying Zhang; Gang Tian; Xuemei Ding; Shiping Bai; Jianping Wang; Li Lv; Huanwei Peng; Yue Xuan; Quifeng Zeng
Journal:  J Anim Sci Biotechnol       Date:  2022-07-15

2.  Effect of Feed Additives as Alternatives to In-feed Antimicrobials on Production Performance and Intestinal Clostridium perfringens Counts in Broiler Chickens.

Authors:  Silje Granstad; Anja B Kristoffersen; Sylvie L Benestad; Siri K Sjurseth; Bruce David; Line Sørensen; Arnulf Fjermedal; Dag H Edvardsen; Gorm Sanson; Atle Løvland; Magne Kaldhusdal
Journal:  Animals (Basel)       Date:  2020-02-03       Impact factor: 2.752

3.  Research Note: The administration schedule of coccidia is a major determinant in broiler necrotic enteritis models.

Authors:  Evelien Dierick; Richard Ducatelle; Filip Van Immerseel; Evy Goossens
Journal:  Poult Sci       Date:  2020-11-05       Impact factor: 3.352

Review 4.  Short and Medium Chain Fatty Acids and Their Derivatives as a Natural Strategy in the Control of Necrotic Enteritis and Microbial Homeostasis in Broiler Chickens.

Authors:  Luis-Miguel Gomez-Osorio; Veronica Yepes-Medina; Anne Ballou; Manuela Parini; Roselina Angel
Journal:  Front Vet Sci       Date:  2021-12-14

5.  Associations of Transcription Factor 21 Gene Polymorphisms with the Growth and Body Composition Traits in Broilers.

Authors:  Linyong Shen; Jiaqiang Yu; Yaowen Ge; Hui Li; Yumao Li; Zhiping Cao; Peng Luan; Fan Xiao; Haihe Gao; Hui Zhang
Journal:  Animals (Basel)       Date:  2022-02-08       Impact factor: 2.752

6.  A Poultry Subclinical Necrotic Enteritis Disease Model Based on Natural Clostridium perfringens Uptake.

Authors:  Wanwei He; Emanuele C Goes; Jeremy Wakaruk; Daniel R Barreda; Douglas R Korver
Journal:  Front Physiol       Date:  2022-06-08       Impact factor: 4.755

7.  Re-calculating the cost of coccidiosis in chickens.

Authors:  Damer P Blake; Jolene Knox; Ben Dehaeck; Ben Huntington; Thilak Rathinam; Venu Ravipati; Simeon Ayoade; Will Gilbert; Ayotunde O Adebambo; Isa Danladi Jatau; Muthusamy Raman; Daniel Parker; Jonathan Rushton; Fiona M Tomley
Journal:  Vet Res       Date:  2020-09-14       Impact factor: 3.683

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.